Shivaswamy, Vijay
Nebraska Medical Center · VA Nebraska Western Iowa Health Care System · University of Nebraska Medical Center
4 papers on CoChatORCID 0000-0002-3301-4965
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews
Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes
Cited by 328
- Verified
A retrospective study of glucagon-like peptide 1 receptor agonists for the management of diabetes after transplantation
Thangavelu, T., Lyden, E., & Shivaswamy, V. (2020) · Diabetes Therapy
Diabetes Treatment and ManagementRenal Transplantation Outcomes and Treatments
Cited by 96
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free